1. Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature
   Lacy E. Lowry et al, 2017, Frontiers in Immunology CrossRef
2. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1
   Youqiong Ye et al, 2020, Genome Medicine CrossRef
3. Presumed Roles of APRO Family Proteins in Cancer Invasiveness
   Yuka Ikeda et al, 2022, Cancers CrossRef
4. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
   K.G.K. Deepak et al, 2020, Pharmacological Research CrossRef
5. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy
   Iván Carrera-Aguado et al, 2024, International Journal of Molecular Sciences CrossRef
6. Immune checkpoint activity exacerbate renal interstitial fibrosis progression by enhancing PD-L1 expression in renal tubular epithelial cells
   Yuting Zhang et al, 2024, Translational Research CrossRef
7. High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer
   Hyung Suk Kim et al, 2021, PLOS ONE CrossRef
8. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence
   Prashanth K.B. Nagesh et al, 2019, ACS Applied Materials & Interfaces CrossRef
9. MMP2 is a immunotherapy related biomarker and correlated with cancer-associated fibroblasts infiltrate in melanoma
   Kunwei Peng et al, 2023, Cancer Cell International CrossRef
10. Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability
    Tao Wu et al, 2023, BMC Medicine CrossRef
11. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target
    Vida Hashemi et al, 2020, International Immunopharmacology CrossRef
12. Optimization of the fermentation process of Cordyceps sobolifera Se-CEPS and its anti-tumor activity in vivo
    Shengli Yang et al, 2016, Journal of Biological Engineering CrossRef
13. Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity
    Barbara Seliger, 2019, Frontiers in Immunology CrossRef
14. Integrated Bioinformatics-Based Analysis of Hub Genes and the Mechanism of Immune Infiltration Associated With Acute Myocardial Infarction
    Yanze Wu et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
15. Identification of Prognostic Stromal-Immune Score–Based Genes in Hepatocellular Carcinoma Microenvironment
    Shanshan Liu et al, 2021, Frontiers in Genetics CrossRef
16. Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer
    Xuan Lin et al, 2022, Translational Oncology CrossRef
17. CTLA-4 silencing could promote anti-tumor effects in hepatocellular
    Amirhossein Mardi et al, 2024, Medical Oncology CrossRef
18. Immunotherapy for Triple-Negative Breast Cancer
    Yifeng Cao et al, 2021, Pharmaceutics CrossRef
19. Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives
    Farhad Seif et al, 2023, Molecular Therapy - Oncolytics CrossRef
20. Extract of Caulis Spatholobi, a novel blocker targeting tumor cell-induced platelet aggregation, inhibits breast cancer metastasis
    Xi Chen et al, 2016, Oncology Reports CrossRef